Nisin-induced changes in<i>Bacillus</i>morphology suggest a paradigm of antibiotic action

Alexander J. Hyde1, Judicaël Parisot1, Adam McNichol1, Boyan B. Bonev1
1School of Biomedical Sciences and Institute of Infection and Immunity, University of Nottingham, Nottingham NG7 2UH, United Kingdom.

Tóm tắt

Nisin is a small cationic lanthionine antibiotic produced byLactococcus lactis. During its antimicrobial action, it targets intermediates in the bacterial cell-wall biosynthesis, lipid II, and undecaprenyl pyrophosphate. Here, we report results from electron microscopic investigations of the effects of lethal nisin doses onBacillus subtiliscell morphology. Bacterial membranes were permeabilized shortly afterB. subtiliswas incubated with nisin, but this did not lead to immediate cell death. Cell division, as well as other life functions, persisted over at least half an hour after nisin was added. Slower bacterial elongation, consistent with cell envelope inhibition and accelerated division, resulted in cell-length reduction. Abnormal morphogenesis near the division site suggests this to be the primary site of nisin action. Morphological changes are characteristic of deregulation of a filamentous cell envelope protein, Mbl, and the division-inhibiting Min system. We propose a previously undescribed model, in which the lethal action of nisin againstB. subtilisstarts with membrane permeabilization and is followed by accelerated cell division, cell envelope inhibition, and aberrant cell morphogenesis.

Từ khóa


Tài liệu tham khảo

10.1128/jb.16.4.211-229.1928

J Delves-Broughton, P Blackburn, RJ Evans, J Hugenholtz Int J Gen Mol Microbiol 69, 193–202 (1996).

10.1128/aem.41.2.375-380.1981

10.1128/aem.60.6.1962-1968.1994

J Delves-Broughton Food Technol 44, 100–117 (1990).

LV Thomas, MR Clarkson, J Delves-Broughton Natural Food Antimicrobial Systems, ed AS Naidu (CRC, New York), pp. 463–524 (2000).

10.1021/ja00747a073

10.1021/bi0001170

10.1021/bi000915q

10.1021/bi970008u

10.1128/aem.56.8.2551-2558.1990

10.1126/science.286.5448.2361

10.1074/jbc.M006770200

10.1096/fj.04-2358com

10.1128/AAC.27.5.841

10.1016/0014-5793(96)00638-2

H-G Sahl Nisin and Novel Lantibiotics, eds G Jung, H-G Sahl (ESCOM, Leiden, The Netherlands), pp. 347–358 (1991).

10.1002/j.2050-0416.1987.tb04472.x

10.1128/AAC.50.4.1449-1457.2006

10.1128/MMBR.62.1.181-203.1998

10.1016/S0092-8674(03)00421-5

10.1073/pnas.0600829103

10.1016/S1534-5807(01)00014-4

10.1073/pnas.90.3.1053

10.1038/nrm1745

10.1128/JB.186.17.5775-5781.2004

10.1128/JB.186.12.3951-3959.2004

10.1016/0092-8674(85)90290-9

10.1128/jb.177.3.765-773.1995

10.1016/S0092-8674(01)00287-2

10.1111/j.1365-2958.2005.04736.x

10.1016/S0005-2736(99)00208-4

10.1128/jb.124.1.459-469.1975

10.1016/S0006-291X(77)80094-6

10.1002/pmic.200300416

EM Scholar, WB Pratt The Antimicrobial Drugs (Oxford Univ Press, 2nd Ed., New York, 2000).

10.1126/science.1129818

10.1128/JB.185.1.196-203.2003

10.1074/jbc.M500895200

10.1128/aem.59.1.213-218.1993

10.1038/176510b0

10.1021/ac60150a040